Research Topics
| Christopher DaughertySummaryAffiliation: University of Chicago Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
What are terminally ill cancer patients told about their expected deaths? A study of cancer physicians' self-reports of prognosis disclosureChristopher K Daugherty
Department of Medicine, Section of Hematology Oncology, MacLean Center for Clinical Medical Ethics, and Cancer Research Center, The University of Chicago, Chicago, IL 60637, USA
J Clin Oncol 26:5988-93. 2008..Little is known about how physicians discuss prognosis with terminally ill cancer patients. Thus, we sought to obtain cancer physicians' self-reports of their prognosis communication practices...
Overcoming obstacles to hospice care: an ethical examination of inertia and inactionChristopher K Daugherty
Department of Medicine, MacLean Center for Clinical Medical Ethics, the Cancer Research Center at the University of Chicago, IL, USA
J Clin Oncol 20:2752-5. 2002- Overcoming obstacles to hospice care: an ethical examination of inertia and inactionChristopher K Daugherty
Department of Medicine, MacLean Center for Clinical Medical Ethics, the Cancer Research Center at the University of Chicago, and Vitas Hospice, Chicago, IL 60637-1470, USA
J Clin Oncol 21:42s-45s. 2003 - Attitudes toward research participation and investigator conflicts of interest among advanced cancer patients participating in early phase clinical trialsStacy W Gray
Section of Hematology, Cancer Research Center, Committee on Clinical Pharmacology and Pharmacogenomics, MacLean Center for Clinical Medical Ethics, University of Chicago, Chicago, IL 60637, USA
J Clin Oncol 25:3488-94. 2007.... - Examining ethical dilemmas as obstacles to hospice and palliative care for advanced cancer patientsChristopher K Daugherty
Department of Medicine, MacLean Center for Clinical Medical Ethics, Cancer Research Center, University of Chicago, Chicago, Illinois, USA
Cancer Invest 22:123-31. 2004.... - American oncologists' views of internet use by cancer patients: a mail survey of American Society of Clinical Oncology membersPaul R Helft
Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA
J Clin Oncol 21:942-7. 2003..Americans are turning more and more frequently to the Internet to obtain health information. The specific effects on patients, doctors, and the clinical encounter are not well known... - Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantationAndrew S Artz
Section of Hematology Oncology, University of Chicago, Chicago, Illinois 60637, USA
Biol Blood Marrow Transplant 12:954-64. 2006..001) and enhanced prognostic power over the CCI alone (P = .018). Prospective studies evaluating more comprehensive functional and comorbidity measurements are warranted... - A phase I trial of gemcitabine plus cladribine in patients with advanced hematologic malignant diseasesOlatoyosi M Odenike
Section of Hematology Oncology, Department of Medicine, University of Chicago, 5841 S Maryland Avenue, MC 2115, Chicago, IL 60637 1470, USA
Cancer Chemother Pharmacol 54:553-61. 2004.... - Physician preferences and knowledge gaps regarding the care of childhood cancer survivors: a mailed survey of pediatric oncologistsTara O Henderson
University of Chicago, Section of Pediatric Hematology, Oncology and Stem Cell Transplantation, 5841 S Maryland Ave, MC 4060, Chicago, IL 60637, USA
J Clin Oncol 28:878-83. 2010..18 to 2.52) were more likely to have answered all three questions correctly. CONCLUSION Pediatric oncologists express a range of preferences with regard to LTFU of CCS. Many appear unfamiliar with LTFU surveillance guidelines... 
An international pilot study of oncology physicians' opinions and practices on Complementary and Alternative Medicine (CAM)Richard T Lee
Department of Medicine, Section of Hematology Oncology, University of Chicago, Chicago, IL 60637, USA
Integr Cancer Ther 7:70-5. 2008..Because of a long cultural history of CAM, we hypothesized that oncologists in China and Taiwan (C/T) would communicate and combine CAM with conventional treatments more often than US oncologists...- Treatment of therapy-related myeloid neoplasms with high-dose cytarabine/mitoxantrone followed by hematopoietic stem cell transplantLucy A Godley
Section of Hematology Oncology, Department of Medicine, The University of Chicago, Chicago, IL, USA
Leuk Lymphoma 51:995-1006. 2010..The remission induction of high-dose cytarabine and mitoxantrone for t-MN is a well-tolerated efficacious combination, which allows aggressive consolidation and long-term disease-free survival... - Ethical issues in phase I clinical trialsChristopher K Daugherty
University of Chicago, IL, USA
Clin Adv Hematol Oncol 2:358-60. 2004 - Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trialsChristopher K Daugherty
University of Chicago, Pritzker School of Medicine, 5841 South Maryland Ave, MC 2115, Chicago, IL 60637 1463, USA
J Clin Oncol 26:1371-8. 2008..To examine the ethical, scientific, and regulatory issues in the design and conduct of placebo-controlled cancer clinical trials... - Housestaff and medical student attitudes toward medical errors and adverse eventsPamela D Vohra
Department of Medicine, Beth Israel Deaconess Medical Center, Boston, USA
Jt Comm J Qual Patient Saf 33:493-501. 2007..A lack of formal patient safety curricula has contributed to the suboptimal training of medical students and housestaff. Attitudes of physician trainees regarding medical errors and adverse events were surveyed in a pilot study... - Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision makingFay J Hlubocky
Department of Medicine, Section of Hematology Oncology, MacLean Center for Clinical Medical Ethics, The Cancer Research Center, The University of Chicago, Chicago, IL 60637, USA
J Clin Oncol 25:548-54. 2007..We sought to describe complementary and alternative medicine (CAM) usage among phase I trial participants and to describe these patients' treatment decision-making preferences, awareness of prognosis, survival, and quality of life... - Trusting God and medicine: spirituality in advanced cancer patients volunteering for clinical trials of experimental agentsChristopher K Daugherty
Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL 60612-3833, USA
Psychooncology 14:135-46. 2005..One phase I patient who said, 'I put faith in doctors and God,' expressed these patients' willingness to trust both God and medicine... - Use of the internet to obtain cancer information among cancer patients at an urban county hospitalPaul R Helft
Department of Medicine, Division of Hematology Oncology, The Indiana University Cancer Center, Indianapolis, IN 46202, USA
J Clin Oncol 23:4954-62. 2005..To evaluate rates, predictors, and barriers to use of the Internet to obtain cancer information among a cohort of cancer patients at an urban county hospital... - Associations among awareness of prognosis, hopefulness, and coping in patients with advanced cancer participating in phase I clinical trialsPaul R Helft
Department of Medicine, The Regenstrief Institute for Health Care, Indiana University School of Medicine, Indianapolis, Indiana, USA
Support Care Cancer 11:644-51. 2003..In this study, the relationships among awareness of prognosis, hopefulness, and coping were examined in a selected group of ACP... - How often do BRCA mutation carriers tell their young children of the family's risk for cancer? A study of parental disclosure of BRCA mutations to minors and young adultsAngela R Bradbury
Department of Medicine, Section of Hematology Oncology, University of Chicago, Chicago, IL, USA
J Clin Oncol 25:3705-11. 2007..Yet, many BRCA mutation carriers discuss their results with their children. This study describes the prevalence and experiences of parental communication of BRCA results to children under the age of 25 years old... - Are we taking without giving in return? The ethics of research-related biopsies and the benefits of clinical trial participationPaul R Helft
J Clin Oncol 24:4793-5. 2006 - 'Hitting you over the head': oncologists' disclosure of prognosis to advanced cancer patientsElisa J Gordon
Neiswanger Institute for Bioethics and Health Policy, Rm 280, Stritch School of Medicine, Bldg 120, Loyola University of Chicago, 2160 S First Avenue, Maywood, IL 60153, USA
Bioethics 17:142-68. 2003..We discuss these data in light of the cultural, ethical, and legal dimensions of prognosis disclosure, patient hope and the doctor-patient relationship, and recommend ways to enhance the communication process... - The "cure" for cancer: can the media report the hope without the hype?Christopher K Daugherty
J Clin Oncol 20:3761-4. 2002
Research Grants
- Ethics and Clinical Trials in Advanced Cancer CareChristopher Daugherty; Fiscal Year: 2003....
- Ethics and Clinical Trials in Advanced Cancer CareChristopher Daugherty; Fiscal Year: 2007....
- Ethics and Clinical Trials in Advanced Cancer CareChristopher Daugherty; Fiscal Year: 2009....